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Bariatric surgery, hyperoxaluria, 
and nephrolithiasis: A plea for 
close postoperative management 
of risk factors
JG Kleinman1
Hyperoxaluria contributes significant risk for kidney stone 
development. It can result from disordered metabolism, excessive 
intake of oxalate or other nutrients, or alterations of bowel flora and 
function. Sinha et al. show that individuals undergoing Roux-en-Y 
bypass have high rates of stone disease, both before and after their 
procedure. Whether or not the incidence of stone events is increased 
after surgery, hyperoxaluria should be addressed. After Roux-en-Y, it is 
important for patients to maintain high urine outputs, to limit fat intake, 
and to ingest adequate amounts of calcium.
Kidney International (2007) 72, 8–10. doi:10.1038/sj.ki.5002284
Somewhat overshadowed in the hulla-
baloo surrounding the increase in obes-
ity, metabolic syndrome, cardiovascular 
disease, and chronic kidney disease in 
the developed world is that these condi-
tions are also associated with an increased 
incidence of kidney stones. Th is increased 
incidence has been largely of calcium 
stones, mainly those composed of calcium 
oxalate, but also to some extent of uric acid 
kidney stones. Rates of nephrolithiasis in 
the United States and in most developing 
countries have been increasing, and these 
increases correlate with rates of hyperten-
sion, diabetes, and obesity.
Urinary risk factors for nephrolithiasis 
include low urine volume, hypercalciuria, 
hyperoxaluria, and hypocitraturia. Hype-
ruricosuria, oddly, is primarily a risk fac-
tor for calcium stones, and low urine pH, 
especially in the context of insulin resist-
ance, is a signifi cant risk factor for uric acid 
stones.1 Th e pathophysiologic connections 
between the epidemiologic and the urinary 
risk factors are closer in some cases than in 
others; for example, the relation between 
insulin resistance and low urine pH is bet-
ter understood than that of hypertension 
and hypercalciuria.
For some reason, the role of hyperoxalu-
ria in the pathophysiology of stone disease 
has been underemphasized, at least as 
compared with the role of hypercalciuria. 
Comparative searches using PubMed, 
done several ways, yield only 55%–60% 
the numbers of results for hyperoxaluria 
than they yield for hypercalciuria.Yet, as 
has been emphasized by Tiselius, hyper-
oxaluria has a more profound eff ect on 
the relative supersaturation for calcium 
oxalate than do increases in urinary cal-
cium.2 In addition, it appears that higher 
oxalate-to-calcium ratios favor forma-
tion of larger numbers of smaller calcium 
oxalate crystals as compared with lower 
oxalate-to-calcium ratios.3 Th is would 
be expected to increase the likelihood 
of stone development as well as leading 
to the exhaustion of factors in urine that 
inhibit crystal attachment to renal tubule 
cells or to each other.
Underlining these theoretical conside-
rations are the strong relation between 
hyperoxaluria and stone rates reported 
by Robertson and Hughes4 and the strik-
ingly high rate of calcium oxalate kidney 
stones that occurs in infl ammatory bowel 
disease.5 Genetic hyperoxaluria, which 
can be caused by different gene muta-
tions, is characterized by a wide range of 
hyperoxaluria, from not very much above 
the normal upper range to orders of mag-
nitude higher.6 In general, there is a direct 
relationship between stone incidence and 
the degree of hyperoxaluria.
Figure 1 shows a highly schematic pic-
ture of the routes taken by ingested oxalate 
or oxalate precursors. Alimentary hyper-
oxaluria can be due to excessive intake 
of these substances. However, not only is 
there controversy regarding the bioavaila-
bility of much of the oxalate in the diet; 
the mainly plant sources of dietary oxalate 
are rarely ingested in excessive quantities 
or even on a regular basis.7 Aft er all, how 
many rhubarb or Swiss chard addicts are 
there? And the recent spinach scare, if 
anything, is likely to have decreased intake 
of this otherwise estimable vegetable. 
Excessive absorption of dietary oxalate 
ingested in conventional amounts, how-
ever, may be present under a number of 
diff erent circumstances.
When intestinal calcium is limited 
because of low intake, dietary oxalate 
absorption is apparently enhanced, pre-
sumably because the lack of calcium 
prevents sequestration of oxalate in the 
intestinal lumen in the form of poorly 
soluble calcium oxalate. Consequently, 
when stone formers are placed on a low-
calcium diet, urinary oxalate goes up.8 
Th e result of this is an increase in relative 
supersaturation of calcium oxalate and a 
demonstrated increase in the stone recur-
rence rate. Dietary calcium and calcium 
supplements that are ingested with meals 
have been shown to lower oxalate absorp-
tion and, hence, urinary excretion.
Some investigators have proposed that 
altered intestinal fl ora can be responsible 
for hyperoxaluria. Oxalobacter formi-
genes, an intestinal saprophyte, is obli-
gated to use oxalate as its energy source. 
Loss of this organism via broad-spectrum 
antibiotic treatment has been associated 
with hyperoxaluria, and provision of the 
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organism in the form of a probiotic has 
been proposed as a treatment for recur-
rent calcium oxalate stone disease.9
Bowel disease is a more complicated 
situation. Loss of oxalate-metabolizing 
O. formigenes through treatments with 
non-absorbable antibiotics may occur. 
However, the most likely explanation is the 
reduction of lumen calcium by its precipi-
tation in the form of insoluble long-chain 
fatty acid salts, preventing its interaction 
with oxalate to form insoluble calcium 
oxalate.5 It is also possible that dihydroxy 
bile acids within the lumen of the colon 
due to bile acid malabsorption lead to 
increased permeability of colonic mucosa 
to oxalate. Th e hyperoxaluria observed 
with jejunoileal bypass operations, a cur-
rently discredited procedure to treat mor-
bid obesity, is probably a consequence of 
one or both of these mechanisms.
Reaction of intestinal calcium with 
fatty acids may also be responsible for 
the direct relationship between protein 
intake and oxalate excretion, as increases 
in the former usually refl ect animal pro-
tein and are thus generally paralleled by 
increased fat intake. If high fat intake were 
combined with low calcium intake or not 
compensated for by appropriate increases 
in calcium intake, one could speculate that 
some excess long-chain fatty acids might 
be present to produce calcium soaps with 
the available calcium. Th is would prevent 
the reaction of calcium with oxalate, lead-
ing to excessive absorption of the latter. 
High-protein diets may also contribute 
to hyperoxaluria by increasing intake of 
hydroxyproline and tryptophan, which are 
then metabolized to oxalate.10 Some com-
bination of these factors may be respon-
sible for the mild hyperoxaluria that we 
have oft en observed in our stone patients. 
On the other hand, it is possible that less 
active isoforms of the anion exchanger 
CFEX, also known as Slc26a6, which may 
mediate intestinal oxalate secretion, lead 
to increased net absorption, as has been 
demonstrated in mice with this gene dele-
tion.11
Th e report by Sinha et al.12 (this issue) 
has brought to our attention another 
clinical situation in which hyperoxalu-
ria occurs: Roux-en-Y bypass performed 
for morbid obesity. In our experience at 
the Medical College of Wisconsin, obese 
stone formers often have mild hyper-
oxaluria. Although the mean preopera-
tive oxalate excretion in a representative 
sample of patients undergoing the surgery 
was within the normal range, the standard 
deviation indicates that as many as one-
third of patients could have been some-
what above the normal range.12
Aft er surgery, the mean oxalate content 
in the urine of stone-forming patients was 
clearly above the normal range. In a pro-
spectively studied cohort, oxaluria was 
not abnormal at 6 months aft er the proce-
dure but was clearly elevated at a year. Th e 
mechanism responsible for hyperoxaluria 
in these patients could not be readily dis-
cerned, although limitation of intestinal 
calcium, as described above, is discussed. 
Whatever its etiology, hyperoxaluria was 
clearly the signifi cantly abnormal stone 
risk factor in these patients. Th is is under-
lined by the observations that the other 
stone constituents either remained under-
saturated or their saturation was less than 
that of the range of normal individuals.
So, what are we to tell those unfortu-
nate individuals who are contemplating 
undertaking the signifi cant risks of this 
bariatric procedure to improve their 
already considerable burden of morbid-
ity or to avoid worsening of their medical 
problems? Are kidney stones yet another 
risk they must endure? To decide this, we 
must first inquire whether Roux-en-Y 
bypass increases the likelihood of de novo 
nephrolithiasis or favors the recurrence of 
stones in individuals who already have the 
tendency to form them.
Among the stone patients reported by 
Sinha et al.12 from whom urine chemis-
tries were available, 32% had preexisting 
nephrolithiasis. Th is is similar to the pro-
portion of prior nephrolithiasis among 
the patients in the cross-sectional study 
included in the paper. Extrapolating 
that proportion to the total number of 
patients undergoing Roux-en-Y bypass 
gives a fi gure of over 400 individuals, 
among these patients, who had preex-
isting stone disease. Th is is not unex-
pected, as obesity and the other medical 
conditions that are common among 
these patients — hypertension, diabetes, 
and metabolic syndrome — appear to 
be associated with a higher prevalence 
of stone disease.13,14 Assuming a stone 
event recurrence rate of 5% per year 
among stone formers, the more than 
400 individuals with preexisting disease 
might be expected to have had about 
Figure 1 | The routes taken by ingested oxalate or oxalate precursors. Ca, calcium; 
Ox, oxalate.
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65 recurrences, which is similar to the 
number of stone events collected in the 
report by Sinha et al.12
Th us, it would be incorrect, in my opin-
ion, to conclude from this paper that the 
new onset of stone disease is yet another 
risk that patients contemplating Roux-
en-Y bypass must face as a consequence 
of having the procedure. Th ey are already 
at risk for stone disease and stone events. 
What this important study clearly shows 
is that the principal risk factor for the 
development of stones aft er this proce-
dure is hyperoxaluria. The important 
conclusion that should be drawn from 
these observations is that stone risk fac-
tors, particularly hyperoxaluria, need to 
be addressed postoperatively in these 
patients. Presumably, this would involve, 
as always, sufficient water to ensure a 
urine output of greater than 2 liters per 
day. But, in addition, limitation of fat 
and provision of suffi  cient calcium with 
meals, either from dietary sources or in 
the form of supplements, would be of 
particular importance for this group of 
patients. Pyridoxine is unlikely to be of 
benefi t in these individuals.15
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